Modified rye bread helps patients with irritable bowel syndrome
- Date:
- July 18, 2016
- Source:
- Wiley
- Summary:
- Patients with irritable bowel syndrome (IBS) are often concerned that certain foods may trigger or worsen their symptoms, which can include abdominal pain, diarrhea, or constipation. In a new study, patients who ate rye bread that was low in so-called 'FODMAPs' (fermentable oligo- di- and mono-saccharides and polyols) experienced milder IBS symptoms than patients who ate normal rye bread.
- Share:
Patients with irritable bowel syndrome (IBS) are often concerned that certain foods may trigger or worsen their symptoms, which can include abdominal pain, diarrhea, or constipation. In a new study, patients who ate rye bread that was low in so-called "FODMAPs" (fermentable oligo- di- and mono-saccharides and polyols) experienced milder IBS symptoms than patients who ate normal rye bread.
Patients with IBS who are considering a low FODMAP diet should first discuss it with their doctor. A low FODMAP diet cuts out most fruits and grains and would not, otherwise, be recommended or considered healthy.
"Our study shows that reduction of FODMAP content of a major food staple, such as rye bread, may reduce some symptoms of IBS but is not enough per se to reach adequate overall symptom control in IBS. It's likely that a holistic low-FODMAP diet is needed in most cases in order to reach adequate control of overall symptoms," said Dr. Reijo Laatikainen, lead author of the Alimentary Pharmacology & Therapeutics study. "Low-FODMAP rye bread seems to be one way to increase fiber intake of patients with IBS. Just like the rest of the population, IBS patients tend to have a lower than recommended intake of fiber," he added.
Story Source:
Materials provided by Wiley. Note: Content may be edited for style and length.
Journal Reference:
- R. Laatikainen, J. Koskenpato, S.-M. Hongisto, J. Loponen, T. Poussa, M. Hillilä, R. Korpela. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 2016; DOI: 10.1111/apt.13726
Cite This Page: